|
WO0220770A1
|
|
Method of screening antitumor agent by using interaction between arf protein and hk33 protein
|
|
WO0206520A1
|
|
Method of screening compound controlling mek/erk signal transduction and medicinal use of the compound
|
|
WO0198492A1
|
|
Novel transcription factor having zinc finger domain
|
|
AU5265101A
|
|
Sex determinative differentiation regulatory factor
|
|
AU1891801A
|
|
Method of screening remedy for cancer with the use of interaction domains of p53 and mortalin
|
|
WO0144470A1
|
|
Novel human rna helicase, helicain
|
|
WO0123555A1
|
|
Method of prolonging normal cell life span
|
|
AU7445900A
|
|
Novel hemopoietin receptor protein, nr12
|
|
WO0121792A1
|
|
Transporter genes oatp-b, c, d and e
|
|
AU6731200A
|
|
Gene YS68 concerning early hematopoiesis
|
|
WO0112808A1
|
|
Novel frizzled family genes 584
|
|
WO0110905A1
|
|
Medicinal compositions for inhibiting abnormal proliferation of vascular smooth muscle cells
|
|
AU6181000A
|
|
Novel genes encoding protein kinase/protein phosphatase
|
|
WO0153482A1
|
|
VITAMIN D3-RESPONSE SEQUENCE LOCATED IN THE 5'-UPSTREAM OF p27/KiP1 GENE AND METHOD FOR SCREENING DRUG BY USING THE SEQUENCE
|
|
WO0075314A1
|
|
Novel hemopoietin receptor protein nr10
|
|
WO0072670A1
|
|
Lkb1 gene knockout animals
|
|
AU5103100A
|
|
Novel cytokine
|
|
WO0065047A1
|
|
Tumor suppressor genes
|
|
AU3674000A
|
|
Novel fetal genes
|
|
AU3326300A
|
|
Method for screening anticancer agent
|
